LYZL2 and Hyperglycemia: In addition to shared hyperglycemia‐responsive genes, we also detected higher levels of lysozyme 2 (Lyz2), a marker of fibroblasts/fibrocytes of circulating myeloid cell origin,34 in fibroblasts from the STZ treatment group.